The changes in the following mentioned parameters as a result of the upper airway obstruction and subsequent ventilation–perfusion ratio. A. PAO 2: ________ _ increased; ________ decreased; _ remained the same B. PACO 2 : ____ _ increased; ________ decreased; _ remained the same C. PCO 2 : _ increased; __ decreased; _ remained the same D. PC CO2 : increased; __ decreased; _ remained the same E. pH: ________ _ increased; ______ decreased; _ remained the same Introduction: Upper airway obstruction is a clinical condition characterized by the presence of blockage in the upper airway that includes the trachea, the larynx, or the voice box, and the throat. Blockage in the upper airway prevents the body from getting enough oxygen. Upper airway obstruction leads to the diminishing of pulmonary ventilation. Please refer to Clinical Application Case-2 for further information.

Question

19. On the diagram below a. Label the three pictures as: DNA; polypeptide; or RNA. b. Label the arrows as: translation or transcription/RNA processing. c. Add the following details to the diagram. Promoter region TATA box Transcription start site Transcription terminator Intron (A,B,C,D) Exons (1,2,3,4,5) Splice sites 5' cap 5' UTR (untranslated region) 3' poly A tail 3' UTR (untranslated region) Translational start (AUG) Translational stop (UGA, UAG, or UAA) N and C ends of polypeptide 0000

Answer 1

Question

Chapter 8, Problem 2CAQ3

Summary Introduction

To review:

The changes in the following mentioned parameters as a result of the upper airway obstruction and subsequent ventilation–perfusion ratio.

A. PAO_{2: ________ _} increased; ______ decreased; _ remained the same

B. PACO₂: _{______ _} increased; ______ decreased; _ remained the same

C. PCO₂: _{___} increased; decreased; _ remained the same

D. PC_CO2: _{__} increased; decreased; _ remained the same

E. pH: _{__________ _} increased; ______ decreased; _ remained the same

Introduction:

Upper airway obstruction is a clinical condition characterized by the presence of blockage in the upper airway that includes the trachea, the larynx, or the voice box, and the throat. Blockage in the upper airway prevents the body from getting enough oxygen. Upper airway obstruction leads to the diminishing of pulmonary ventilation.

Please refer to Clinical Application Case-2 for further information.

Expert Solution & Answer

Trending nowThis is a popular solution!

See solution

Check out sample textbook solution

Students have asked these similar questions

19. On the diagram below a. Label the three pictures as: DNA; polypeptide; or RNA. b. Label the arrows as: translation or transcription/RNA processing. c. Add the following details to the diagram. Promoter region TATA box Transcription start site Transcription terminator Intron (A,B,C,D) Exons (1,2,3,4,5) Splice sites 5' cap 5' UTR (untranslated region) 3' poly A tail 3' UTR (untranslated region) Translational start (AUG) Translational stop (UGA, UAG, or UAA) N and C ends of polypeptide 0000

Match the letter labels in the figure below to the terms. Some letter labels are not used. MNNNNNNIN M C B A M D F E H K G 8

The diagram below illustrates a quorum sensing pathway from Staphylococcus aureus. Please answer the following questions. 1. Autoinduction is part of the quorum sensing system. Which promoter (P2 or P3) is critical for autoinduction? 2)This staphylococcus aureus grows on human wounds, causing severe infections. You would like to start a clinical trial to treat these wound infections. Please describe: a) What molecule do you recommend for the trial. Why? b) Your trial requires that Staphylococcus aureus be isolated from the wound and submitted to genome sequencing before admittance. Why? What are you testing for? 3) If a mutation arises where the Promoter P3 is constitutively active, how would that influence sensitivity to AIP? Please explain your rationale. 4) This pathway is sensitive to bacterial cell density. Describe two separate mutation that would render the pathway active independent of cell density. Briefly explain your rationale. Mutation 1 Mutation 2